OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/05/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
INDERO CRO
ST13
US500000079412141Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Charles G. Zug Nelson Mullins Riley & Scarborough LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Distributorship services for others in the fields of cameras and imaging equipment for use in the field of dermatology and laboratory equipment for use in the field of clinical research; electronic data collection services for business purposes in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; collection and compilation of information into computer databases in the field of preclinical and nonclinical research, clinical trials and technical studies related to pharmaceutical and biological drugs for human and veterinary use
Classe 42
Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information on the design and management of clinical trials; Scientific research in relation to the design and management of clinical trials and development of clinical trials in the fields of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical and scientific research, namely, designing, developing protocols for, organizing, conducting, monitoring, and managing clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products for others; Consulting services for others in the field of medical and scientific research, namely, clinical trials and preclinical and nonclinical research studies, research support services and research project management services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Calibration services, namely, the calibration of electronic data for the purpose of conducting clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Electronic storage of data in the field of clinical trials and preclinical and nonclinical research studies related to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Medical research services, namely, research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products; Scientific research in relation to the designing and conducting of clinical trials in the fields of data management and biostatistics; Providing scientific information on the design and management of clinical trials and preclinical and nonclinical research studies; Research assistance services and research project management services for the purpose of designing and conducting clinical trials in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, and medical devices
Classe 44
Medical testing services in relation to subjects in clinical trials of pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices and other therapeutic products
Classe 45
Regulatory compliance consulting and advisory services in relation to pharmaceutical and biologic drugs for human and veterinary use, natural health products, medical devices
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/05/2026
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/05/2026
REGISTERED-PRINCIPAL REGISTER
19/05/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/05/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/05/2026
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/03/2026
PUBLISHED FOR OPPOSITION
31/03/2026
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2026
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2026
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
05/03/2026
RESPONSE TO ITU OFFICE ACTION ENTERED
26/02/2026
TEAS VOLUNTARY AMENDMENT RECEIVED
26/02/2026
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/02/2026
EXAMINER'S AMENDMENT ENTERED
20/02/2026
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/02/2026
EXAMINERS AMENDMENT E-MAILED
20/02/2026
EXAMINERS AMENDMENT -WRITTEN
20/02/2026
TEAS REQUEST TO DIVIDE RECEIVED
10/02/2026
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2025
FINAL REFUSAL E-MAILED
09/09/2025
FINAL REFUSAL WRITTEN
09/09/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
15/08/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/08/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/08/2025
REFUSAL PROCESSED BY IB
08/03/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/02/2025
REFUSAL PROCESSED BY MPU
18/02/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/01/2025
NON-FINAL ACTION WRITTEN
06/01/2025
ASSIGNED TO EXAMINER
26/12/2024
APPLICATION FILING RECEIPT MAILED
13/12/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/12/2024
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2024
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.